Next Article in Journal
Epidemiology and Prevention of Renal Cell Carcinoma
Previous Article in Journal
Controversial Link between Cannabis and Anticancer Treatments—Where Are We and Where Are We Going? A Systematic Review of the Literature
Previous Article in Special Issue
HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer
 
 
Editorial

Article Versions Notes

Cancers 2022, 14(16), 4058; https://doi.org/10.3390/cancers14164058
Action Date Notes Link
article pdf uploaded. 22 August 2022 16:03 CEST Version of Record https://www.mdpi.com/2072-6694/14/16/4058/pdf-vor
article xml file uploaded 23 August 2022 10:06 CEST Original file -
article xml uploaded. 23 August 2022 10:06 CEST Update https://www.mdpi.com/2072-6694/14/16/4058/xml
article pdf uploaded. 23 August 2022 10:06 CEST Updated version of record https://www.mdpi.com/2072-6694/14/16/4058/pdf
article html file updated 23 August 2022 10:37 CEST Original file -
article html file updated 24 August 2022 21:26 CEST Update https://www.mdpi.com/2072-6694/14/16/4058/html
Back to TopTop